PURIT Trademark

Trademark Overview

On Thursday, June 20, 2019, a trademark application was filed for PURIT with the United States Patent and Trademark Office. The USPTO has given the PURIT trademark a serial number of 88481194. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, January 17, 2022. This trademark is owned by Myst Therapeutics, Inc.. The PURIT trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceutical products for the prevention and treatment of cancer, immunotherapy products, namely, pharmaceutical preparations for the treatment of cancer and tumors; pharmaceutical preparations for T Cell therapy; biological preparations for the treatment of cancer and tumors
purit

General Information

Serial Number88481194
Word MarkPURIT
Filing DateThursday, June 20, 2019
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, January 17, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 22, 2019

Trademark Statements

Goods and Servicespharmaceutical products for the prevention and treatment of cancer, immunotherapy products, namely, pharmaceutical preparations for the treatment of cancer and tumors; pharmaceutical preparations for T Cell therapy; biological preparations for the treatment of cancer and tumors

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSunday, June 30, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameMyst Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressLos Angeles, CA 90066
Party NameMyst Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressLos Angeles, CA 90066

Trademark Events

Event DateEvent Description
Tuesday, January 18, 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, January 17, 2022ABANDONMENT - NO USE STATEMENT FILED
Friday, October 15, 2021WITHDRAWAL OF ATTORNEY GRANTED
Friday, October 15, 2021TEAS WITHDRAWAL OF ATTORNEY RECEIVED
Thursday, October 14, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, October 14, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, October 14, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, October 14, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, October 14, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, June 18, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, June 16, 2021EXTENSION 3 GRANTED
Wednesday, June 16, 2021EXTENSION 3 FILED
Wednesday, June 16, 2021TEAS EXTENSION RECEIVED
Thursday, December 10, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, December 8, 2020EXTENSION 2 GRANTED
Tuesday, December 8, 2020EXTENSION 2 FILED
Tuesday, December 8, 2020TEAS EXTENSION RECEIVED
Friday, June 19, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, June 17, 2020EXTENSION 1 GRANTED
Wednesday, June 17, 2020EXTENSION 1 FILED
Wednesday, June 17, 2020TEAS EXTENSION RECEIVED
Tuesday, December 17, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 22, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 22, 2019PUBLISHED FOR OPPOSITION
Wednesday, October 2, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, September 18, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, September 12, 2019ASSIGNED TO EXAMINER
Sunday, June 30, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, June 24, 2019NEW APPLICATION ENTERED IN TRAM

Related Keywords

purit pharmaceutical preparations treatment cancer tumors products therapy biological cell immunotherapy